BNP Paribas Financial Markets’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

BNP Paribas Financial Markets’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-231	Closed	-$31.3K	–	4817
2022 Q2	$31.3K	Hold	231	–	–	﹤0.01%	3649
2022 Q1	$34.5K	Sell	231 -513	-69%	-$75.9K	﹤0.01%	3627
2021 Q4	$120K	Sell	744 -10	-1%	-$1.62K	﹤0.01%	3541
2021 Q3	$125K	Buy	754 +194	+35%	+$33.1K	﹤0.01%	3199
2021 Q2	$96.7K	Buy	560 +166	+42%	+$27.4K	﹤0.01%	3052
2021 Q1	$63.2K	Buy	+394	New	+$67.5K	﹤0.01%	3530

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SOS

Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

BNP Paribas Financial Markets's FBT Position: Q3 2022 in Review

BNP Paribas Financial Markets sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2022, closing a stake of 231 shares — an estimated $31.3K sold.

BNP Paribas Financial Markets first reported a position in FBT in Q1 2021 and held it in 6 quarters. The position peaked at $125K in Q3 2021. 218 funds tracked by Wall St. Rank hold FBT as of Q3 2022.

BNP Paribas Financial Markets reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2022 after selling out during the quarter.
BNP Paribas Financial Markets sold 231 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2022, an estimated $31.3K.
BNP Paribas Financial Markets first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2021 and held it in 6 quarters.
BNP Paribas Financial Markets's First Trust NYSE Arca Biotechnology Index Fund position peaked at $125K in Q3 2021.
218 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2022, filed 15 Nov 2022.